Business Description
Arvee Laboratories (India) Ltd
ISIN : INE006Z01016
Share Class Description:
NSE:ARVEE: Ordinary SharesCompare
Compare
Traded in other countries / regions
ARVEE.India IPO Date
2018-02-22Description
Arvee Laboratories (India) Ltd is an India based specialty chemicals company. The company products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.54 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.28 | |||||
| Interest Coverage | 6 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 14.89 | |||||
| Beneish M-Score | -3.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.9 | |||||
| 3-Year EBITDA Growth Rate | -25.3 | |||||
| 3-Year EPS without NRI Growth Rate | -32.8 | |||||
| 3-Year Book Growth Rate | 10.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.55 | |||||
| 9-Day RSI | 51.2 | |||||
| 14-Day RSI | 49.66 | |||||
| 6-1 Month Momentum % | 7.25 | |||||
| 12-1 Month Momentum % | 61.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.11 | |||||
| Quick Ratio | 2.23 | |||||
| Cash Ratio | 1.03 | |||||
| Days Inventory | 124.22 | |||||
| Days Sales Outstanding | 93.5 | |||||
| Days Payable | 140.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 1.33 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.24 | |||||
| Operating Margin % | 4.94 | |||||
| Net Margin % | 3.47 | |||||
| FCF Margin % | 13.58 | |||||
| ROE % | 3.67 | |||||
| ROA % | 2.82 | |||||
| ROIC % | 3.28 | |||||
| ROC (Joel Greenblatt) % | 8.72 | |||||
| ROCE % | 6.83 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 202.32 | |||||
| PE Ratio without NRI | 202.32 | |||||
| Shiller PE Ratio | 105.93 | |||||
| Price-to-Owner-Earnings | 49.57 | |||||
| PS Ratio | 7 | |||||
| PB Ratio | 7.43 | |||||
| Price-to-Tangible-Book | 7.43 | |||||
| Price-to-Free-Cash-Flow | 51.63 | |||||
| Price-to-Operating-Cash-Flow | 31.73 | |||||
| EV-to-EBIT | 98.71 | |||||
| EV-to-EBITDA | 57.37 | |||||
| EV-to-Revenue | 6.76 | |||||
| EV-to-FCF | 49.8 | |||||
| Price-to-Projected-FCF | 3.81 | |||||
| Price-to-Graham-Number | 8.18 | |||||
| Price-to-Net-Current-Asset-Value | 16.33 | |||||
| Earnings Yield (Greenblatt) % | 1.01 | |||||
| FCF Yield % | 1.95 | |||||
| Forward Rate of Return (Yacktman) % | -4.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arvee Laboratories (India) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 303.452 | ||
| EPS (TTM) (₹) | 0.95 | ||
| Beta | 1.74 | ||
| Volatility % | 70.5 | ||
| 14-Day RSI | 49.66 | ||
| 14-Day ATR (₹) | 10.15204 | ||
| 20-Day SMA (₹) | 189.9945 | ||
| 12-1 Month Momentum % | 61.01 | ||
| 52-Week Range (₹) | 103.6 - 315 | ||
| Shares Outstanding (Mil) | 11.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arvee Laboratories (India) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arvee Laboratories (India) Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arvee Laboratories (India) Ltd Frequently Asked Questions
What is Arvee Laboratories (India) Ltd(NSE:ARVEE)'s stock price today?
The current price of NSE:ARVEE is ₹192.20. The 52 week high of NSE:ARVEE is ₹315.00 and 52 week low is ₹103.60.
When is next earnings date of Arvee Laboratories (India) Ltd(NSE:ARVEE)?
The next earnings date of Arvee Laboratories (India) Ltd(NSE:ARVEE) is .
Does Arvee Laboratories (India) Ltd(NSE:ARVEE) pay dividends? If so, how much?
Arvee Laboratories (India) Ltd(NSE:ARVEE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers